Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease

Renal Effects of Long-Term Treatment with 5-Aminosalicylic Acid

(2016) Harshna Patel et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Mesalazine in Inflammatory Bowel Disease: A Trendy Topic Once Again?

(2016) Marietta Iacucci et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis

(2010) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis

(2010) William J. Sandborn et al.   GASTROENTEROLOGY

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

(2010) W. Reinisch et al.   GUT

Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX®with Asacol®

(2009) C. PRANTERA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis

(2009) Axel U. Dignass et al.   Clinical Gastroenterology and Hepatology

Accidentally ASCENDing Into Comparative Effective Research for Inflammatory Bowel Disease

(2009) Corey A. Siegel   GASTROENTEROLOGY

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

(2009) Filip Baert et al.   GASTROENTEROLOGY

Importance of mucosal healing in ulcerative colitis

(2009) Gary R. Lichtenstein et al.   INFLAMMATORY BOWEL DISEASES

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

(2008) W Kruis et al.   GUT

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis

(2008) Michael A. Kamm et al.   INFLAMMATORY BOWEL DISEASES